<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Chem Eng and Analytical Science</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BF70D1E4-7D79-470E-8FDA-B260542F605C"><gtr:id>BF70D1E4-7D79-470E-8FDA-B260542F605C</gtr:id><gtr:firstName>Hans</gtr:firstName><gtr:otherNames>Victor</gtr:otherNames><gtr:surname>Westerhoff</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/073E03D7-B407-4785-897B-DF4D39A3CE59"><gtr:id>073E03D7-B407-4785-897B-DF4D39A3CE59</gtr:id><gtr:firstName>Pedro</gtr:firstName><gtr:surname>Mendes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3FBB74D2-493A-4815-8D7F-EA2493F589AB"><gtr:id>3FBB74D2-493A-4815-8D7F-EA2493F589AB</gtr:id><gtr:firstName>Jacob</gtr:firstName><gtr:otherNames>Leendert</gtr:otherNames><gtr:surname>Snoep</gtr:surname><gtr:orcidId>0000-0002-0405-8854</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI00470X%2F1"><gtr:id>00347E00-1E85-4583-8EC1-B85567046628</gtr:id><gtr:title>Modelling carbon core metabolism in Bacillus subtilis - Exploring the contribution of protein complexes in core carbon and nitrogen metabolism</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I00470X/1</gtr:grantReference><gtr:abstractText>Fires can be extinguished in two ways. One uses pumps with pipes that fill up a ditch (the 'pool') that leads to where the fire is, and then another pump taking out the water squirting it onto the fire. The other one is a line of people where the first fills each bucket in a nearby river and then hands the full bucket to the person next in line, who hands it to the next-next, etcetera, i.e. the 'bucket-brigade' mechanism. The chemistry of how living organisms extract energy and carbon out of their food is organized in terms of pathways. This organization could use either the pool mechanism or the bucket brigade mechanism. In most of the text books on this topic it is assumed that it is the pool mechanism that operates, but this is mainly because this is simpler to understand and more readily examined experimentally. Accordingly, mathematical models of the chemistry of living cells tend to assume that pool mechanisms are operative. The biological 'machines' that carry out the individual steps/chemical reactions in the pathways are called enzymes. In recent work in an important bacterium, it has been discovered that some of these enzymes embrace each other, i.e. form complexes. This proposal aims at defining and understanding the impact of metabolic and regulatory multienzyme complexes on the central carbon and nitrogen metabolism. It will do this in Bacillus subtilis, a highly tractable model organism for systems biology approaches. It will examine whether any observed impact is through the facilitation of the bucket-brigade mechanism (also called metabolic channelling). It will do this through a close integration of modelling and experimentation. The outcome of this project could greatly change our understanding of the chemistry of Life. It could also lead to new ways of interfering with that chemistry, for instance by breaking up or promoting the enzyme-enzyme love affairs. Implications could be in the domains of the production of food and chemicals by microorganisms (beer, bread, wine, gasohol) and health management, but would require follow-up projects.</gtr:abstractText><gtr:technicalSummary>Based on the finding in the first funding period of SYSMO that glycolytic enzymes of B. subtilis form complexes, we wish to define the role of enzyme complexes in the physiology of B. subtilis at the Systems level. To this end, we will first quantify the concentrations of relevant cellular components (proteins, mRNAs, metabolites). Asking whether enzyme concentrations are identical or otherwise stoichiometric to each other and asking for metabolic over- and undershoots around enzymes, we will identify candidates for enzyme-enzyme complexes. In parallel, we will identify protein complexes involved in glycolysis, in tricarboxylic acid cycle, in gluconeogenesis and in anabolic and stress-induced proline synthesis, by implementing our established complex isolation methodology. After an initial validation of these potential complexes by bacterial two-hybrid screening, we will compare these to the above mentioned candidates and come to a combined list of more likely candidates. Meanwhile integral kinetic models of the pathways will be built (topological, then blueprint kinetic), and populated with the measured enzyme concentrations and literature kinetic data. The metabolic fluxes will be determined during balanced growth. By comparing model prediction with experimental results for fluxes and metabolite concentrations, first functional indications for metabolite channelling or alteration of enzyme kinetics upon complexation, will be identified. The promising candidate complexes will then be studied in more detail: We will provide evidence for the in vivo interaction of the partners in the complexes in single cells of B. subtilis using fusions to fluorescent proteins and time lapse and confocal microscopy. Moreover, we will determine kinetic parameters of the interactions to obtain data needed for refined modelling and to select the most relevant candidate complexes for detailed analysis. For these key complexes, we will study the dynamic behaviour.</gtr:technicalSummary><gtr:potentialImpactText>From the research planned by our consortium we expect to obtain for the first time ever a clear picture of the functional role of protein complexes in bacterial physiology. The outcomes will represent a major advance in our understanding of the metabolism of B. subtilis, an organism of high biotechnological relevance. Moreover, we will contribute to the general understanding of metabolic compartments in bacteria, leading to new strategies for metabolic modeling that take the existence and importance of such complexes into account. Finally, with our research program, which involves extensive collaboration between several European laboratories, our consortium will strengthen the European research community and the collaborations within this community. Last, but not least, there will certainly be important results to be published that will increase the visibility of European science in general, and European microbial Systems Biology in particular.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-02-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-11-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>339161</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The work has produced mathematical models of the metabolism of this organism. These are used by us and others for further work relevant for potential industrial use of this organisms and for understanding its medical dangers.</gtr:description><gtr:id>7A378418-8CF3-40C0-90B0-14970315D14D</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d95613003392.02031745</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Education,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Mathematical models on carbon and energy metabolism of this organism</gtr:description><gtr:exploitationPathways>Scientific literature and conferences</gtr:exploitationPathways><gtr:id>877005C2-3118-4C9A-8D09-1683672A1C6C</gtr:id><gtr:outcomeId>56d956eba0b077.83192554</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Education,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Steatosis or fatty liver disease is an important disease sometimes leading to hepatocarcinoma. Most researchers engaged in genomics are searching for so-called candidate genes in their data, which then should identify single-gene causes and single target strategies. We have developed a way to identify/examine 'candidate pathways'.
More inn general, the portfolio of projects ahs led to a great increase in number of detailed kinetic models of metabolic pathways (as reported in JWS-Online). these are now of great use for other organisms and the same pathways or other pathways in the same organisms. All these models are also of use for the development of the Infrastructure Systems Biology Europe (ISBE).</gtr:description><gtr:id>D79BD662-AA59-4E20-BAC9-FD48909056E0</gtr:id><gtr:impact>This is now used in multiple research projects. Through JWS online and BioModels our models are used by many.</gtr:impact><gtr:outcomeId>58c99951d8a554.74201952</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Candidate pathway finding</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E0D3C70B-6B45-4821-803C-F867320E71E9</gtr:id><gtr:title>(Im)Perfect robustness and adaptation of metabolic networks subject to metabolic and gene-expression regulation: marrying control engineering with metabolic control analysis.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373d1c654ca2691bb8d71b2cc74294c3"><gtr:id>373d1c654ca2691bb8d71b2cc74294c3</gtr:id><gtr:otherNames>He F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>5675d93ad32dd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9A5B451-CA9C-417F-81BA-203CA8A5FE75</gtr:id><gtr:title>AmtB-mediated NH3 transport in prokaryotes must be active and as a consequence regulation of transport by GlnK is mandatory to limit futile cycling of NH4(+)/NH3.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c585a5e86738d6a053aa7af8f5d6bf37"><gtr:id>c585a5e86738d6a053aa7af8f5d6bf37</gtr:id><gtr:otherNames>Boogerd FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>56758e706f64c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D9AB56-962F-41D0-87CC-9BAEC4F7D10A</gtr:id><gtr:title>Hierarchical regulation</gtr:title><gtr:parentPublicationTitle>Comparative Biochemistry and Physiology a-Molecular &amp; Integrative Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f90e89ee64ed2d201595c14703e019b"><gtr:id>2f90e89ee64ed2d201595c14703e019b</gtr:id><gtr:otherNames>Bakker, B.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1095-6433</gtr:issn><gtr:outcomeId>58bc965317e2a7.02987315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6DE568A-375C-4D3E-81AA-C6A24FF57DD8</gtr:id><gtr:title>Adenine nucleotide translocator - A candidate for mediating long chain acyl-CoA effects in type 2 diabetes</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32906616eaf2c7fe96ac926ae1b65420"><gtr:id>32906616eaf2c7fe96ac926ae1b65420</gtr:id><gtr:otherNames>Bakker, S. J. L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc9650d39f28.64246868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E772C2C-CABF-4E83-ABF8-492EDE1815AB</gtr:id><gtr:title>Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.</gtr:title><gtr:parentPublicationTitle>Scientific data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c005ea75e6acb36657fc353b743eff0"><gtr:id>2c005ea75e6acb36657fc353b743eff0</gtr:id><gtr:otherNames>Wruck W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2052-4463</gtr:issn><gtr:outcomeId>58bc964d04a064.52807348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72C024E3-5127-467D-8090-607DDAC98D38</gtr:id><gtr:title>Summation theorems for flux and concentration control coefficients of dynamic systems.</gtr:title><gtr:parentPublicationTitle>Systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d7d347dc73fdd1e77e7299a0387eb0"><gtr:id>e5d7d347dc73fdd1e77e7299a0387eb0</gtr:id><gtr:otherNames>Conradie R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1741-2471</gtr:issn><gtr:outcomeId>58bc9653787c22.07523674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA75D8F5-4FA3-4CB3-A2B3-5E41DA346F89</gtr:id><gtr:title>Why in vivo may not equal in vitro - new effectors revealed by measurement of enzymatic activities under the same in vivo-like assay conditions.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d8e48a0ed01ae269c02979f6f9ba31f"><gtr:id>3d8e48a0ed01ae269c02979f6f9ba31f</gtr:id><gtr:otherNames>Garc?a-Contreras R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_5435a8c5a8c05ad47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B7D996E-8030-4E59-8EF1-0F160887BE8A</gtr:id><gtr:title>Control of kinases and phosphatases on signaling kinetics.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Association for Cancer Research Annual Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf170fc7a1f9eb543f3abab853cc1402"><gtr:id>bf170fc7a1f9eb543f3abab853cc1402</gtr:id><gtr:otherNames>Binder, Bernd</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0197-016X</gtr:issn><gtr:outcomeId>58bc96568e0b75.81697163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E7BF876-4FC5-44B9-9B86-6C677C747AFE</gtr:id><gtr:title>Systems Biology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cbba07be8f17855eaadf39b7b412334"><gtr:id>1cbba07be8f17855eaadf39b7b412334</gtr:id><gtr:otherNames>Westerhoff H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0947-6075;978-3-540-</gtr:issn><gtr:outcomeId>58bc96524868c3.62272612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86A18D0F-B853-4506-889B-861059EC38FD</gtr:id><gtr:title>Modular Kinetic Analysis of the Adenine Nucleotide Translocator-Mediated Effects of Palmitoyl-CoA on the Oxidative Phosphorylation in Isolated Rat Liver Mitochondria</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e45c451fdbf2325b07977d58e008d56"><gtr:id>5e45c451fdbf2325b07977d58e008d56</gtr:id><gtr:otherNames>Ciapaite J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58bc96554315d0.22506347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39397199-C814-4527-A992-B1028044B342</gtr:id><gtr:title>Monte-Carlo modeling of the central carbon metabolism of Lactococcus lactis: insights into metabolic regulation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e247afb31f495685799f256dd44df4"><gtr:id>63e247afb31f495685799f256dd44df4</gtr:id><gtr:otherNames>Murabito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675dc084f723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F6312CF-F76D-4CAE-AE1C-3D3170757AB3</gtr:id><gtr:title>Metabolic control analysis to identify optimal drug targets.</gtr:title><gtr:parentPublicationTitle>Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8225ab7ff2537ec2036411646bf0c83"><gtr:id>d8225ab7ff2537ec2036411646bf0c83</gtr:id><gtr:otherNames>Hornberg JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0071-786X</gtr:issn><gtr:outcomeId>58bc96518eaf34.49369557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CB0D381-D258-4185-AE92-A1A6C64BD522</gtr:id><gtr:title>Systems biology of chemotherapy in hypoxia environments</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c54fd83abb820761764dfe7f28fb9fc7"><gtr:id>c54fd83abb820761764dfe7f28fb9fc7</gtr:id><gtr:otherNames>Armitage, Emily</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>58bc964e274a02.36356295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B45EA04-7453-4DDF-87F0-23A971FB82F3</gtr:id><gtr:title>'Domino' systems biology and the 'A' of ATP.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13612d272764df84675aaca216a4839a"><gtr:id>13612d272764df84675aaca216a4839a</gtr:id><gtr:otherNames>Verma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5675d796c1b60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04D6B08B-EA45-4F8D-B78A-E4346BF9618F</gtr:id><gtr:title>Systems biology of HIF metabolism in cancer</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c54fd83abb820761764dfe7f28fb9fc7"><gtr:id>c54fd83abb820761764dfe7f28fb9fc7</gtr:id><gtr:otherNames>Armitage, Emily</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>58bc964dc00128.15006853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D17C5753-1A39-4A6E-B566-D2929462CD5B</gtr:id><gtr:title>Systems biology: Robustness through adaption and regeneration</gtr:title><gtr:parentPublicationTitle>Calcified Tissue International</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec50642a6d41865891b96407bb82cae8"><gtr:id>ec50642a6d41865891b96407bb82cae8</gtr:id><gtr:otherNames>Westerhoff, H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-967X</gtr:issn><gtr:outcomeId>58bc9654842935.75549203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E912EB3F-016A-42A3-A109-A3943A98DBDC</gtr:id><gtr:title>Introduction to systems biology.</gtr:title><gtr:parentPublicationTitle>Exs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ec9b2473024b18b64be38fbdc32f9"><gtr:id>b09ec9b2473024b18b64be38fbdc32f9</gtr:id><gtr:otherNames>Boogerd, Fred C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1023-294X</gtr:issn><gtr:outcomeId>58bc96513811f8.49281426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8839D813-A7C9-43DE-8A12-0BE2F764E681</gtr:id><gtr:title>Structural and dynamic features of the eukaryotic translation initiation pathway</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/789bbc99bc1d25fa91cedd08357426f5"><gtr:id>789bbc99bc1d25fa91cedd08357426f5</gtr:id><gtr:otherNames>Bryant, H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc965072f046.34088598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CB4BC30-D0C3-44E8-A7C4-A08BBCE34CAA</gtr:id><gtr:title>The International Consortium on Systems Biology of Receptor Tyrosine Kinase Regulatory Networks.</gtr:title><gtr:parentPublicationTitle>Systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ab38fdd1a6b0b207dd26bef25a56c0c"><gtr:id>1ab38fdd1a6b0b207dd26bef25a56c0c</gtr:id><gtr:otherNames>Sakaki Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1741-2471</gtr:issn><gtr:outcomeId>58bc96563cdb71.31348304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDCDC3AE-F582-4973-B9FD-DB627CE53132</gtr:id><gtr:title>Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13612d272764df84675aaca216a4839a"><gtr:id>13612d272764df84675aaca216a4839a</gtr:id><gtr:otherNames>Verma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>5675d7f254e1b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCEEB13-C051-4DC5-AFAA-3FE2F3AE8F4B</gtr:id><gtr:title>Systems biology-based drug design: Control of oncogenic signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Association for Cancer Research Annual Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/921551cc42c96dc60d7ce0d6e0a3b40f"><gtr:id>921551cc42c96dc60d7ce0d6e0a3b40f</gtr:id><gtr:otherNames>Bruggeman, Frank J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0197-016X</gtr:issn><gtr:outcomeId>58bc965431be25.07038140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12FE2E11-95BE-4373-BBC7-60D1EBBAADC4</gtr:id><gtr:title>MUFINS: multi-formalism interaction network simulator.</gtr:title><gtr:parentPublicationTitle>NPJ systems biology and applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d32428cc153e7cee2d830d508f768769"><gtr:id>d32428cc153e7cee2d830d508f768769</gtr:id><gtr:otherNames>Wu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2056-7189</gtr:issn><gtr:outcomeId>58bc964c455f47.75583607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6657277-1345-4B2D-B32A-D2D8306CEB57</gtr:id><gtr:title>Targeting pathogen metabolism without collateral damage to the host.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b284bb7cbe0495e1d33020a8ad8f4ad"><gtr:id>1b284bb7cbe0495e1d33020a8ad8f4ad</gtr:id><gtr:otherNames>Haanstra JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bc964b773612.42939997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBC55519-6F81-4FCD-A537-C5CAFA35BA71</gtr:id><gtr:title>Systems Biology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/118b05f3d81d118c4ad89dcef7fd1505"><gtr:id>118b05f3d81d118c4ad89dcef7fd1505</gtr:id><gtr:otherNames>Snoep J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1610-2096</gtr:issn><gtr:outcomeId>58bc9654e1bbf9.88065253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7CE2ED9-E32F-4294-8301-BF85857BF8BE</gtr:id><gtr:title>A probabilistic approach to identify putative drug targets in biochemical networks.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e247afb31f495685799f256dd44df4"><gtr:id>63e247afb31f495685799f256dd44df4</gtr:id><gtr:otherNames>Murabito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>pm_5435a8b5a8b33ced8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0D664DF-8675-4B0A-BDD8-22BDE186D817</gtr:id><gtr:title>Nuclear receptors as controlling factors in chemical metabolism: Determination of regulatory signal network crucial for co-ordinating cellular response to chemicals</gtr:title><gtr:parentPublicationTitle>Drug Metabolism Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/261a1412a1a035a93edb921b99c38cfc"><gtr:id>261a1412a1a035a93edb921b99c38cfc</gtr:id><gtr:otherNames>Bruggeman, Frank</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0360-2532</gtr:issn><gtr:outcomeId>58bc964ec85815.69341880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C34FD2CD-90CA-4C3E-BB01-9D92DF3E09A2</gtr:id><gtr:title>Sulfolobus Systems Biology: Cool Hot Design for Metabolic Pathways</gtr:title><gtr:parentPublicationTitle>Systems Microbiology: Current Topics and Applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39156294cb308686f463b4acfea1a2b4"><gtr:id>39156294cb308686f463b4acfea1a2b4</gtr:id><gtr:otherNames>Kolodkin, Alexey</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-908230-02-7</gtr:isbn><gtr:issn>978-1-908230-02-7</gtr:issn><gtr:outcomeId>58bc964d65d931.64051831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F59CA7-003B-4F3A-B981-228FC738F34A</gtr:id><gtr:title>Exploiting metabolic and gene-expression networks for drug design</gtr:title><gtr:parentPublicationTitle>ICOPA XI: Proceedings of the 11th International Congress of Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aa66d3842ff61d076f0a6a55bb4f405"><gtr:id>1aa66d3842ff61d076f0a6a55bb4f405</gtr:id><gtr:otherNames>Albert, M. -A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:isbn>9788875872731</gtr:isbn><gtr:issn>88-7587-272-4</gtr:issn><gtr:outcomeId>58bc9652a9a2f9.20636526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FF740C1-A3AF-42DD-9679-98B3ED112A3D</gtr:id><gtr:title>Matrix method for determining steps most rate-limiting to metabolic fluxes in biotechnological processes. 1987.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23e765f696328753cfc7c38cedd990a1"><gtr:id>23e765f696328753cfc7c38cedd990a1</gtr:id><gtr:otherNames>Westerhoff HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>58bc964f9edcf9.25454635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>983EDDCC-CE89-491F-997B-B6BFD041EB49</gtr:id><gtr:title>Report of an EU projects workshop on systems biology held in Brussels, Belgium on 8 December 2004.</gtr:title><gtr:parentPublicationTitle>Systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0750d92ab622a1e68d3236e9e5783428"><gtr:id>0750d92ab622a1e68d3236e9e5783428</gtr:id><gtr:otherNames>Birney E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1741-2471</gtr:issn><gtr:outcomeId>58bc96559fb537.52010166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1714E32A-91B9-461C-9472-2ED8CB933D58</gtr:id><gtr:title>Macromolecular networks and intelligence in microorganisms.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23e765f696328753cfc7c38cedd990a1"><gtr:id>23e765f696328753cfc7c38cedd990a1</gtr:id><gtr:otherNames>Westerhoff HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5675db6f3ac49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44F3F36B-ABB0-489D-ADF9-5EF85F338280</gtr:id><gtr:title>Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15fc714b73d80ff53da7e7f6c9282368"><gtr:id>15fc714b73d80ff53da7e7f6c9282368</gtr:id><gtr:otherNames>Geenen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>5675d8453f5d4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D57F5027-94A7-49FD-BB78-D9FB8B2DEC8E</gtr:id><gtr:title>A new regulatory principle for in vivo biochemistry: pleiotropic low affinity regulation by the adenine nucleotides--illustrated for the glycolytic enzymes of Saccharomyces cerevisiae.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f6917a389f181473818df9c837a3eda"><gtr:id>7f6917a389f181473818df9c837a3eda</gtr:id><gtr:otherNames>Mensonides FI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>5675d892c81d0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>067061CB-6F25-4081-AE7D-BFB75A5BA47C</gtr:id><gtr:title>Multi-factorial disease and robustness: Where Systems Biology makes a difference</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabbf1427d9bc0b52c06f23470a9182d"><gtr:id>dabbf1427d9bc0b52c06f23470a9182d</gtr:id><gtr:otherNames>Westerhoff, H. V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc9651ddee55.21098190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAC766C8-DE1E-4FD4-ADCE-B2048ECDA120</gtr:id><gtr:title>Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97f217f2f4312e072c8112fff6185808"><gtr:id>97f217f2f4312e072c8112fff6185808</gtr:id><gtr:otherNames>Dols JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58bc964ca369b1.07659178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E651996-05F8-4817-B556-1C336B5F1EDA</gtr:id><gtr:title>Battling robustness: to make microbes weak</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabbf1427d9bc0b52c06f23470a9182d"><gtr:id>dabbf1427d9bc0b52c06f23470a9182d</gtr:id><gtr:otherNames>Westerhoff, H. V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc965009de00.54790075</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I00470X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>